<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03140540</url>
  </required_header>
  <id_info>
    <org_study_id>RGCI ID:500/AN/ANK-02</org_study_id>
    <nct_id>NCT03140540</nct_id>
  </id_info>
  <brief_title>TEE as a Guide for Fluid Optimization in Major Abdominal Oncosurgery</brief_title>
  <official_title>Transesophageal Echocardiography as a Guide for Fluid Optimization in Major Abdominal Oncosurgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rajiv Gandhi Cancer Institute &amp; Research Center, India</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rajiv Gandhi Cancer Institute &amp; Research Center, India</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Transesophageal echocardiography (TEE) as guide for tailoring perioperative fluid therapy to
      achieve individualized hemodynamic endpoint, target hemodynamic goals of stroke volume index
      (SVI) greater than 35 mL/m2 and cardiac index greater than 2.5 L/min/m2 and tissue oxygen
      delivery.

      Lactate levels as a surrogate indicator of organ perfusion as measured by arterial blood gas
      analysis intraoperatively, after 12 hours and 48 hrs postoperatively
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      TEE as guide for tailoring perioperative fluid therapy to achieve target hemodynamic goals of
      stroke volume index (SVI) greater than 35 mL/m2 and cardiac index greater than 2.5 L/min/m2
      and tissue oxygen delivery.

      GDT (goal directed therapy): continuous infusion of crystalloids 2 mL/kg/h.

      If (velocity time integral) VTI &lt;20, 250 mL colloid bolus administered. Dose repeated every
      10 min until goal of VTI &gt;20 met. Norepinephrine titrated to maintain MAP(mean arterial
      pressure) &gt; 65 mm Hg. Blood transfused for haemoglobin &lt;8 g Lactate levels as a surrogate
      indicator of organ perfusion as measured by arterial blood gas analysis at time of incision
      intraoperatively and after 12 hours and 48 hrs. The incidence of postoperative complications,
      morbidity, mortality, duration of mechanical ventilation and ICU stay.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>TEE as guide for tailoring perioperative fluid therapy to achieve individualized hemodynamic endpoint , target hemodynamic goals of stroke volume index (SVI) greater than 35 mL/m2 and cardiac index greater than 2.5 L/min/m2 and tissue oxygen delivery. Lactate levels as a surrogate indicator of organ perfusion as measured by arterial blood gas analysis intraoperatively , after 12 hours and 48 hrs postoperatively.</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Care Provider)</masking>
    <masking_description>The intensivist taking care of the patient postoperatively not aware of the intervention</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative complications</measure>
    <time_frame>48 hours</time_frame>
    <description>The incidence of postoperative complications in percentage</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>intraoperative fluid</measure>
    <time_frame>intraoperative period (hours)</time_frame>
    <description>Amount of intraoperative fluid in litres to be compared</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>median icu stay</measure>
    <time_frame>1 week</time_frame>
    <description>duration of icu stay</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Fluid Therapy</condition>
  <arm_group>
    <arm_group_label>Group A (stroke volume variation) guided fluid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Stroke volume variation guided intraoperative intravenous fluid will be administered.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B(Study group) TEE guided fluid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Transesophageal echocardiography will be used to guide the fluid therapy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>TEE guided fluid therapy will be administered</intervention_name>
    <description>Transesophageal echocardiography will be used to guide the fluid therapy. Velocity time integral of aorta &lt;20 ,200ml colloid bolus to be administered.</description>
    <arm_group_label>Group B(Study group) TEE guided fluid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Stroke volume variation guided intravenous fluid.</intervention_name>
    <description>Active Comparator: Group A control group (SVV guided fluid ) Stroke volume variation guided intraoperative intravenous fluid will be administered. SVV &gt;10, 200 ml of colloid bolus to be given</description>
    <arm_group_label>Group A (stroke volume variation) guided fluid</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA 1, 2 and 3

          -  Undergoing major abdominal surgery

        Exclusion Criteria:

          -  Any contraindication for TEE probe insertion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>SOUMI PATHAK, MD</last_name>
    <phone>09891620042</phone>
    <email>pathaksoumi@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>ANITA KULKARNI, MD</last_name>
    <phone>9891064785</phone>
    <email>anitackulkarni@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Rajiv Gandhi Cancer Institute</name>
      <address>
        <city>Delhi</city>
        <zip>110085</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>SOUMI PATHAK, MD</last_name>
      <phone>09891620042</phone>
      <email>pathaksoumi@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>ANITA KULKARNI, MD</last_name>
      <phone>9891064785</phone>
      <email>anitackulkarni@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>anita kulkarni, md</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <results_reference>
    <citation>Guarracino F. [The role of transesophageal echocardiography in intraoperative hemodynamic monitoring]. Minerva Anestesiol. 2001 Apr;67(4):320-4. Italian.</citation>
    <PMID>11376533</PMID>
  </results_reference>
  <results_reference>
    <citation>Trinooson CD, Gold ME. Impact of goal-directed perioperative fluid management in high-risk surgical procedures: a literature review. AANA J. 2013 Oct;81(5):357-68. Review.</citation>
    <PMID>24354071</PMID>
  </results_reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 15, 2017</study_first_submitted>
  <study_first_submitted_qc>May 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 4, 2017</study_first_posted>
  <last_update_submitted>May 5, 2017</last_update_submitted>
  <last_update_submitted_qc>May 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rajiv Gandhi Cancer Institute &amp; Research Center, India</investigator_affiliation>
    <investigator_full_name>Dr soumi pathak</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Fluid management</keyword>
  <keyword>goal-directed therapy</keyword>
  <keyword>transesophageal echocardiography</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

